09022833777
Sections
Search
Subscribe
DealCurry
Equity
Venture Capital
Private Equity
M&A

Mergers & Acquisitions | 22 November 2012

Cipla To Acquire Majority Stake In Cipla Medpro

by Charmi Gutka
Cipla To Acquire Majority Stake In Cipla Medpro
Share on Social Media Email Facebook Twitter Linkedin
 
@Charmi

@Cipla_Limited1 Limited is in preliminary discussions and have made an indicative proposal of acquiring approximately a 51% stake in Cipla Medpro South Africa Limited for a total consideration of $220 Mn.

The acquisition will help Cipla to integrate the marketing arm in South Africa with its manufacturing, regulatory and research units.

Johannesburg listed Cipla Medpro is a distributor Cipla Ltd.’s products in South Africa and in some neighboring countries.

Cipla Limited currently does not hold any stake in Cipla Medpro. Medpro used to source 80% of its products from Cipla, and the companies agreed Medpro would use the brand name of Cipla for selling products in Africa.

IncuCapital Invests In Genetic Diagnostic Firm - Navigene

IncuCapital Invests In Genetic Diagnostic Firm - Navigene

VC firm IncuCapital invested an undisclosed amount in Navigene Genetic Science Private Limited.

Read More...

Navayuga Plan To Sell Stake In Its Power Assets

Navayuga Plan To Sell Stake In Its Power Assets

Hyderabad-based CVR Group unit Navayuga Power may sell stake in its power assets to Toshiba, Sumitomo, Mitsubishi & GDF Suez. The deal Value expected to be in between INR 13,800 to 14,400 Mn for equity stake 49 to 51%.

Read More...
DealCurry Timeline
TL Home Search New Keet
CONTACT US
Info@DealCurry.com
09022833777
A 314, 3rd Floor, AntopHill Warehousing Company,
Near Dosti Acres
Wadala(E),
Mumbai 400037
 
   
 
CLIENTS
USEFUL LINKS
SOLUTIONS
Copyright © EagleEye Research & Media Pvt. Ltd. 2009 All Rights Reserved - Interactive multimedia analysis platform for financial markets.
Site map |Terms of Use |Privacy Policy
DealCurry tracks financial and corporate markets for events, interprets and integrates the information in our platform, providing premium data, news and analytics. DealCurry provides comprehensive coverage of the capital markets through an intuitive, user-friendly interface.